Pfizer said on Tuesday its cancer drug Padcev, in combination with Merck's Keytruda, significantly improved survival rates in ...

ABC News' Dr. Tara Narula breaks down a potential non-surgical breakthrough as the FDA fast-tracks review of a ...

The implications are huge. Bladder cancer ranks as the sixth most common cancer in the U.S., affecting around 80,000 people ...

There’s a new twist in the fight against bladder cancer — and it’s delivering game-changing results. In a recent clinical ...

For people facing aggressive bladder cancer that no longer responds to standard treatment, options have often been ...

A new bladder cancer device called TAR-200 kept most patients cancer-free and surgery-free in a trial, with few side effects ...

A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with ...

Deion Sanders announces he battled bladder cancer and is now cancer-free after tumor removal surgery, while doctors share ...

For patients undergoing a radical cystectomy, staying active before and after surgery is key, Dr. Janet Kukreja explained.

Keytruda and Padcev generated promising topline results for those with muscle-invasive bladder cancer who are ineligible for ...

Bladder cancer is often overlooked, but a recent high-profile diagnosis is helping raise awareness. Football legend and ...